Last reviewed · How we verify

NCT03551379

A Double Balloon Endoscopic Platform for ESD

Completed Last updated 20 August 2019
What this trial tests

trial testing Double Balloon Endoluminal Platform in Colon Adenoma in 15 participants. Completed in 29 September 2018.

Timeline
22 September 2017
Primary endpoint
9 March 2018
29 September 2018

Quick facts

Lead sponsorLumendi, LLC
StatusCompleted
Study typeOBSERVATIONAL
Enrollment15
Start date22 September 2017
Primary completion9 March 2018
Estimated completion29 September 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Lumendi, LLC

Who can join

18 and older, any sex, with Colon Adenoma or Colon Polyp. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this observational study is to record performance of a double balloon endolumenal interventional platform during complex colon polypectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Colon Adenoma

Currently open trials in the same condition.

Other Lumendi, LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03551379.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing